Müller T - Search Results

1

Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease.

Krüger R, Menezes-Saecker AM, Schöls L, Kuhn W, Müller T, Woitalla D, Berg D, Berger K, Przuntek H, Epplen JT, Riess O. Krüger R, et al. Among authors: muller t. Neuroreport. 2000 Aug 3;11(11):2439-42. doi: 10.1097/00001756-200008030-00020. Neuroreport. 2000. PMID: 10943700

2

Palinopsia as sensory epileptic phenomenon.

Müller T, Büttner T, Kuhn W, Heinz A, Przuntek H. Müller T, et al. Acta Neurol Scand. 1995 Jun;91(6):433-6. doi: 10.1111/j.1600-0404.1995.tb00442.x. Acta Neurol Scand. 1995. PMID: 7572036

3

Parkinsonism unmasked by lovastatin.

Müller T, Kuhn W, Pöhlau D, Przuntek H. Müller T, et al. Ann Neurol. 1995 May;37(5):685-6. doi: 10.1002/ana.410370527. Ann Neurol. 1995. PMID: 7755369 No abstract available.

4

Distorted color discrimination in 'de novo' parkinsonian patients.

Büttner T, Kuhn W, Müller T, Patzold T, Heidbrink K, Przuntek H. Büttner T, et al. Among authors: muller t. Neurology. 1995 Feb;45(2):386-7. doi: 10.1212/wnl.45.2.386. Neurology. 1995. PMID: 7854545 Clinical Trial.

5

Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

Müller T, Kuhn W, Przuntek H. Müller T, et al. J Neural Transm Gen Sect. 1993;92(2-3):187-95. doi: 10.1007/BF01244877. J Neural Transm Gen Sect. 1993. PMID: 8369108 Review.

6

[Acetylsalicylic acid as free radical scavenger. An argument for increased dosages in acute and preventive therapy of vascular diseases].

Kuhn W, Müller T, Büttner T, Gerlach M. Kuhn W, et al. Among authors: muller t. Fortschr Med. 1995 Nov 30;113(33):483-4. Fortschr Med. 1995. PMID: 8575706 German. No abstract available.

7

Color vision in Parkinson's disease: missing influence of amantadine sulphate.

Büttner T, Kuhn W, Müller T, Patzold T, Przuntek H. Büttner T, et al. Among authors: muller t. Clin Neuropharmacol. 1995 Oct;18(5):458-63. doi: 10.1097/00002826-199510000-00009. Clin Neuropharmacol. 1995. PMID: 8665560

8

The motor performance test series in Parkinson's disease is influenced by depression.

Kuhn W, Heye N, Müller T, Kraus P, Klotz P, Friedrich B, Welter FL, Przuntek H. Kuhn W, et al. Among authors: muller t. J Neural Transm (Vienna). 1996;103(3):349-54. doi: 10.1007/BF01271246. J Neural Transm (Vienna). 1996. PMID: 8739846 Clinical Trial.

9

Plasma levels of the beta-carbolines harman and norharman in Parkinson's disease.

Kuhn W, Müller T, Grosse H, Dierks T, Rommelspacher H. Kuhn W, et al. Among authors: muller t. Acta Neurol Scand. 1995 Dec;92(6):451-4. doi: 10.1111/j.1600-0404.1995.tb00479.x. Acta Neurol Scand. 1995. PMID: 8750109

10

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Blum-Degen D, Müller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. Blum-Degen D, et al. Among authors: muller t. Neurosci Lett. 1995 Dec 29;202(1-2):17-20. doi: 10.1016/0304-3940(95)12192-7. Neurosci Lett. 1995. PMID: 8787820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,492 results

Search Page

Filters